BioLife4D

Early Stage

Build a Heart. Save a life.

Analytics

Raised to Date: Raised: $275,333

Aggregate Commitments $

Platform

Dalmore Group

Start Date

10/23/2020

Close Date

10/23/2021

Min. Goal

$1,080

Max. Goal

$46,133,806

Min. Investment

$1,080

Security Type

Equity - Common

Funding Type

RegA+

Price Per Share

$13.50

Rolling Commitments $

Status
Funded
Reporting Date

10/31/2021

Days Remaining
Funded
% of Min. Goal

25,494%

% of Max. Goal

1%

Likelihood of Max
Funded
Avg. Daily Raise

$754

Momentum
Funded
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

Buffalo Grove, Illinois

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

BioLife4D is raising funds on Dalmore Group through Reg A+ crowdfunding. The company aims to use the current advances in cardiac tissue engineering to build human hearts suitable for implantation. The company will use 3D bioprinting to make patient-specific hearts using the patients’ own cells. The hearts of BioLife4D will have a precise fit and a perfect genetic match. BioLife4D has printed a mini-heart and working on a functional mini-heart for toxicity testing. Steven Morris founded BioLife4D in 2016. The current crowdfunding campaign has no minimum target and a maximum target of $46,133,806. The campaign proceeds will be used for marketing, salaries, rent, equipment, licenses, and working capital.

Balance Sheet

Cash and Cash Equivalents

$1,337,468

Investment Securities

$0

Total Investments

$0

Accounts and Notes Receivable

$0

Loans

$0

Property, Plant and Equipment (PP&E)

$0

Property and Equipment

$0

Total Assets

$1,376,956

Accounts Payable & Accrued Liabilities

$34,077

Policy Liabilities and Accruals

$0

Deposits

$0

Long Term Debt

$850,000

Total Liabilities

$978,580

Total Stockholders' Equity

$398,376

Total Liabilities and Equity

$1,376,956

Statement of Comprehensive Income Information

Total Revenues

$0

Total Interest Income

$0

Costs & Expenses Applicable to Rev

$1,504,757

Total Interest Expenses

$0

Depreciation and Amortization

$0

Net Income

$-1,569,796

Earnings Per Share - Basic

$0

Earnings Per Share - Diluted

$0

Auditor: IndigoSpire
Financials as of: 10/23/2020
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Analyst Reports (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including KingsCrowd ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by KingsCrowd ratings
Company specific KingsCrowd rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
BioLife4D on Dalmore Group 2020
$
Platform: Dalmore Group
Security Type: Equity - Common

Follow company

Follow BioLife4D on Dalmore Group 2020
View on Dalmore Group (Closed)
Bullish / Bearish
You're Bullish on BioLife4D on Dalmore Group 2020

Thank you for your vote on BioLife4D on Dalmore Group 2020

Bullish / Bearish
You're Bearish on BioLife4D on Dalmore Group 2020

Thank you for your vote on BioLife4D on Dalmore Group 2020